Developer of surgical robot platforms and systems for minimally invasive procedures. Its current primary product is a remote master-slave interventional radiotherapy surgical robot, with ongoing research and development. Founded in 2020, headquartered in Zhuhai, China. The company has raised $29.0M in funding at the series a stage. Backed by investors including Proxima Ventures, Huatai Zijin Investment, Yuanbio Venture Capital, Kangze Pharmaceutical. The company operates in High Tech > Professional Service Robots, Life Sciences > Surgical Instruments. Its business models include Professional Service Robots > Healthcare > Surgery > Vascular Intervention, Surgical Instruments > Robotic Surgery. Founded in 2020. Headquartered in China, Zhuhai. The company has raised funding at the Series A stage. Backed by investors including Proxima Ventures, Huatai Zijin Investment, Yuanbio Venture Capital, Kangze Pharmaceutical, Jiangsu Ruihua Investment Holding Group.
← All startups
Hanglok
Series ADeveloper of surgical robot platforms and systems for minimally invasive procedures. Its current primary product is a remote master-slave interventional radiotherapy surgical robot, with ongoing research and development. Founded in 2020, headquartered in Zhuhai, China. The company has raised $29.0M in funding at the series a stage. Backed by investors including Proxima Ventures, Huatai Zijin Investment, Yuanbio…
About
Business model
Professional Service Robots > Healthcare > Surgery > Vascular Intervention,
Surgical Instruments > Robotic Surgery
Institutional investors
Proxima VenturesHuatai Zijin InvestmentYuanbio Venture CapitalKangze PharmaceuticalJiangsu Ruihua Investment Holding Group
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.